René G Feichtinger1, Serge Weis1, Johannes A Mayr1, Franz A Zimmermann1, Barbara Bogner1, Wolfgang Sperl1, Barbara Kofler1. 1. Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria (R.G.F., F.A.Z., B.K.); Laboratory of Neuropathology, Department of Pathology and Neuropathology, State Neuropsychiatric Hospital Wagner-Jauregg, Medical School, Johannes Kepler University, Linz, Austria (S.W.); Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria (J.A.M., W.S.); Department of Ophthalmology, Paracelsus Medical University, Salzburg, Austria (B.B.).
Abstract
BACKGROUND: Changes in the mode of aerobic energy production are observed in many solid tumors, though the kinds of changes differ among tumor types. We investigated mitochondrial energy metabolism in meningiomas and peripheral nerve sheath tumors, taking into consideration the histologic heterogeneity of these tumors. METHODS: Oxidative phosphorylation (OXPHOS) complexes and porin (a marker for mitochondrial mass) were analyzed by immunohistochemical staining of meningiomas (n = 76) and peripheral nerve sheath tumors (schwannomas: n = 10; neurofibromas: n = 4). The enzymatic activities of OXPHOS complexes and citrate synthase were determined by spectrophotometric measurement. Western blot analysis of OXPHOS complexes, porin, and mitochondrial transcription factor A was performed. Furthermore, mitochondrial DNA copy number was determined. RESULTS: The tumors differed with regard to mitochondrial energy metabolism. Low levels of a subset of OXPHOS complexes were frequently observed in World Health Organization grade I meningiomas (percent of cases with a reduction; complex I: 63%; complex II: 67%; complex IV: 56%) and schwannomas (complex III: 40%, complex IV: 100%), whereas in neurofibromas a general reduction of all complexes was observed. In contrast, expression of complexes III and V was similar to that in normal brain tissue in the majority of tumors. Mitochondrial mass was comparable or higher in all tumors compared with normal brain tissue, whereas mitochondrial DNA copy number was reduced. CONCLUSIONS: The reduction of OXPHOS complexes in meningiomas and peripheral nerve sheath tumors has potential therapeutic implications, since respiratory chain-deficient tumor cells might be selectively starved by inhibitors of glycolysis or by ketogenic diet.
BACKGROUND: Changes in the mode of aerobic energy production are observed in many solid tumors, though the kinds of changes differ among tumor types. We investigated mitochondrial energy metabolism in meningiomas and peripheral nerve sheath tumors, taking into consideration the histologic heterogeneity of these tumors. METHODS: Oxidative phosphorylation (OXPHOS) complexes and porin (a marker for mitochondrial mass) were analyzed by immunohistochemical staining of meningiomas (n = 76) and peripheral nerve sheath tumors (schwannomas: n = 10; neurofibromas: n = 4). The enzymatic activities of OXPHOS complexes and citrate synthase were determined by spectrophotometric measurement. Western blot analysis of OXPHOS complexes, porin, and mitochondrial transcription factor A was performed. Furthermore, mitochondrial DNA copy number was determined. RESULTS: The tumors differed with regard to mitochondrial energy metabolism. Low levels of a subset of OXPHOS complexes were frequently observed in World Health Organization grade I meningiomas (percent of cases with a reduction; complex I: 63%; complex II: 67%; complex IV: 56%) and schwannomas (complex III: 40%, complex IV: 100%), whereas in neurofibromas a general reduction of all complexes was observed. In contrast, expression of complexes III and V was similar to that in normal brain tissue in the majority of tumors. Mitochondrial mass was comparable or higher in all tumors compared with normal brain tissue, whereas mitochondrial DNA copy number was reduced. CONCLUSIONS: The reduction of OXPHOS complexes in meningiomas and peripheral nerve sheath tumors has potential therapeutic implications, since respiratory chain-deficient tumor cells might be selectively starved by inhibitors of glycolysis or by ketogenic diet.
Authors: Daniel Monleón; José Manuel Morales; Ana Gonzalez-Segura; José Manuel Gonzalez-Darder; Rosario Gil-Benso; Miguel Cerdá-Nicolás; Concepción López-Ginés Journal: Cancer Res Date: 2010-09-21 Impact factor: 12.701
Authors: Ergün Sahin; Simona Colla; Marc Liesa; Javid Moslehi; Florian L Müller; Mira Guo; Marcus Cooper; Darrell Kotton; Attila J Fabian; Carl Walkey; Richard S Maser; Giovanni Tonon; Friedrich Foerster; Robert Xiong; Y Alan Wang; Sachet A Shukla; Mariela Jaskelioff; Eric S Martin; Timothy P Heffernan; Alexei Protopopov; Elena Ivanova; John E Mahoney; Maria Kost-Alimova; Samuel R Perry; Roderick Bronson; Ronglih Liao; Richard Mulligan; Orian S Shirihai; Lynda Chin; Ronald A DePinho Journal: Nature Date: 2011-02-09 Impact factor: 49.962
Authors: Winward Choy; Won Kim; Daniel Nagasawa; Stephanie Stramotas; Andrew Yew; Quinton Gopen; Andrew T Parsa; Isaac Yang Journal: Neurosurg Focus Date: 2011-05 Impact factor: 4.047
Authors: Franz A Zimmermann; Johannes A Mayr; Rene Feichtinger; Daniel Neureiter; Roman Lechner; Christian Koegler; Manfred Ratschek; Husic Rusmir; Karine Sargsyan; Wolfgang Sperl; Barbara Kofler Journal: Front Biosci (Elite Ed) Date: 2011-01-01
Authors: Rene' G Feichtinger; Daniel Neureiter; Johannes A Mayr; Franz A Zimmermann; Frank Berthold; Neil Jones; Wolfgang Sperl; Barbara Kofler Journal: Front Biosci (Elite Ed) Date: 2011-01-01
Authors: Raphael Johannes Morscher; Sepideh Aminzadeh-Gohari; René Gunther Feichtinger; Johannes Adalbert Mayr; Roland Lang; Daniel Neureiter; Wolfgang Sperl; Barbara Kofler Journal: PLoS One Date: 2015-06-08 Impact factor: 3.240
Authors: Silvia Vidali; Sepideh Aminzadeh-Gohari; René Günther Feichtinger; Renaud Vatrinet; Andreas Koller; Felix Locker; Tricia Rutherford; Maura O'Donnell; Andrea Stöger-Kleiber; Bridget Lambert; Thomas Klaus Felder; Wolfgang Sperl; Barbara Kofler Journal: Oncotarget Date: 2017-07-17
Authors: René G Feichtinger; Daniel Neureiter; Tom Skaria; Silja Wessler; Timothy L Cover; Johannes A Mayr; Franz A Zimmermann; Gernot Posselt; Wolfgang Sperl; Barbara Kofler Journal: Oxid Med Cell Longev Date: 2017-06-28 Impact factor: 6.543
Authors: René G Feichtinger; Georg Schäfer; Christof Seifarth; Johannes A Mayr; Barbara Kofler; Helmut Klocker Journal: Oxid Med Cell Longev Date: 2018-11-14 Impact factor: 6.543
Authors: Jeanine C Pestoni; Stephani Klingeman Plati; Oliver D Valdivia Camacho; Marisa A Fuse; Maria Onatunde; Nicklaus A Sparrow; Matthias A Karajannis; Cristina Fernández-Valle; Maria Clara Franco Journal: J Biol Chem Date: 2019-06-06 Impact factor: 5.157